全文获取类型
收费全文 | 23130篇 |
免费 | 1704篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 306篇 |
儿科学 | 441篇 |
妇产科学 | 509篇 |
基础医学 | 2994篇 |
口腔科学 | 374篇 |
临床医学 | 2747篇 |
内科学 | 4562篇 |
皮肤病学 | 338篇 |
神经病学 | 2000篇 |
特种医学 | 890篇 |
外科学 | 4143篇 |
综合类 | 181篇 |
一般理论 | 50篇 |
预防医学 | 1676篇 |
眼科学 | 577篇 |
药学 | 1547篇 |
中国医学 | 21篇 |
肿瘤学 | 1532篇 |
出版年
2024年 | 6篇 |
2023年 | 224篇 |
2022年 | 166篇 |
2021年 | 926篇 |
2020年 | 509篇 |
2019年 | 870篇 |
2018年 | 941篇 |
2017年 | 681篇 |
2016年 | 726篇 |
2015年 | 821篇 |
2014年 | 1222篇 |
2013年 | 1363篇 |
2012年 | 2237篇 |
2011年 | 2259篇 |
2010年 | 1165篇 |
2009年 | 1074篇 |
2008年 | 1637篇 |
2007年 | 1607篇 |
2006年 | 1439篇 |
2005年 | 1339篇 |
2004年 | 1137篇 |
2003年 | 1002篇 |
2002年 | 829篇 |
2001年 | 108篇 |
2000年 | 72篇 |
1999年 | 62篇 |
1998年 | 87篇 |
1997年 | 63篇 |
1996年 | 33篇 |
1995年 | 25篇 |
1994年 | 32篇 |
1993年 | 22篇 |
1992年 | 17篇 |
1991年 | 14篇 |
1990年 | 9篇 |
1989年 | 18篇 |
1988年 | 15篇 |
1987年 | 8篇 |
1986年 | 13篇 |
1985年 | 15篇 |
1984年 | 10篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1971年 | 3篇 |
1968年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Improving hyperpolarized 129Xe ADC mapping in pediatric and adult lungs with uncertainty propagation
3.
4.
Robinson Sandra M. Scott Jason Ryan Sarah Adams Nicola Hassell Andrew Walker David 《Clinical rheumatology》2022,41(12):3869-3877
Clinical Rheumatology - Educating patients about methotrexate is a core role of rheumatology nurses. We have previously reported the scoring of videoed interviews of rheumatology nurses educating... 相似文献
5.
Loren Saulsberry PhD Ankur Bhargava MD MPH Sharon Zeng BA Jason B. Gibbons PhD Cody Brannan MS Diane S. Lauderdale PhD Robert D. Gibbons PhD 《Health services research》2023,58(4):873-881
Objective
To derive and validate a new ecological measure of the social determinants of health (SDoH), calculable at the zip code or county level.Data Sources and Study Setting
The most recent releases of secondary, publicly available data were collected from national U.S. health agencies as well as state and city public health departments.Study Design
The Social Vulnerability Metric (SVM) was constructed from U.S. zip-code level measures (2018) from survey data using multidimensional Item Response Theory and validated using outcomes including all-cause mortality (2016), COVID-19 vaccination (2021), and emergency department visits for asthma (2018). The SVM was also compared with the existing Centers for Disease Control and Prevention's Social Vulnerability Index (SVI) to determine convergent validity and differential predictive validity.Data Collection/Extraction Methods
The data were collected directly from published files available to the public online from national U.S. health agencies as well as state and city public health departments.Principal Findings
The correlation between SVM scores and national age-adjusted county all-cause mortality was r = 0.68. This correlation demonstrated the SVM's robust validity and outperformed the SVI with an almost four-fold increase in explained variance (46% vs. 12%). The SVM was also highly correlated (r ≥ 0.60) to zip-code level health outcomes for the state of California and city of Chicago.Conclusions
The SVM offers a measurement tool improving upon the performance of existing SDoH composite measures and has broad applicability to public health that may help in directing future policies and interventions. The SVM provides a single measure of SDoH that better quantifies associations with health outcomes. 相似文献6.
7.
Naveen Pemmaraju MD Jacqueline S. Garcia MD Andrew Perkins MBBS PhD Jason G. Harb PhD Andrew J. Souers PhD Michael E. Werner PhD Christopher M. Brown PhD Francesco Passamonti MD 《Cancer》2023,129(22):3535-3545
Myelofibrosis is a heterogeneous myeloproliferative neoplasm characterized by chronic inflammation, progressive bone marrow failure, and hepatosplenic extramedullary hematopoiesis. Treatments like Janus kinase inhibitor monotherapy (e.g., ruxolitinib) provide significant spleen and symptom relief but demonstrate limited ability to lead to a durable disease modification. There is an urgent unmet medical need for treatments with a novel mechanism of action that can modify the underlying pathophysiology and affect the disease course of myelofibrosis. This review highlights the role of B-cell lymphoma (BCL) protein BCL-extra large (BCL-XL) in disease pathogenesis and the potential role that navitoclax, a BCL-extra large/BCL-2 inhibitor, may have in myelofibrosis treatment. 相似文献
8.
9.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
10.